Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04905290 · ClinicalTrials.gov registry record · NA
Conduction System Pacing Optimized Therapy
A NA study, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT04905290 is a NA study that has completed, run by Medtronic Cardiac Rhythm and Heart Failure. The registered enrollment target is 60 participants.
The verdict
NCT04905290, a NA study, has completed, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
The purpose of the CSPOT study is to determine the best mode of cardiac resynchronization therapy (CRT) pacing for different populations of CRT patients, comparing traditional biventricular or left ventricular pacing (BiV), conduction system pacing (CSP)-only, and conduction system pacing optimized therapy (CSPOT) also known as a combination of conduction system pacing (CSP) and left ventricular (LV) pacing. Additionally, safety of the system will be assessed.
Interventions
- DEVICE Left ventricular coronary sinus (BiV) configuration
- DEVICE Conduction system pacing-only configuration
- DEVICE Conduction System Pacing Optimized Therapy (CSPOT) configuration
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2021-11-27 |
| Est. Completion | 2023-11-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04905290
The ClinicalTrials.gov registry entry for NCT04905290 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Cardiac Rhythm and Heart Failure, which has 115 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Left ventricular coronary sinus (BiV) configuration is the first listed.
NCT04905290 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04905290 about?
NCT04905290 is a clinical study titled "Conduction System Pacing Optimized Therapy". The purpose of the CSPOT study is to determine the best mode of cardiac resynchronization therapy (CRT) pacing for different populations of CRT patients, comparing traditional biventricular or left ventricular pacing (BiV), conduction system pacing (CSP)-only, and conduction system pacing optimized ...
What is the current status of trial NCT04905290?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2021-11-27. Estimated completion is 2023-11-02.
What interventions are being tested in trial NCT04905290?
The interventions under investigation include: Left ventricular coronary sinus (BiV) configuration (DEVICE), Conduction system pacing-only configuration (DEVICE), Conduction System Pacing Optimized Therapy (CSPOT) configuration (DEVICE).
Who is sponsoring clinical trial NCT04905290?
This trial is sponsored by Medtronic Cardiac Rhythm and Heart Failure, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.